Loading...
XNYS
TMO
Market cap257bUSD
Oct 30, Last price  
697.00USD
1D
-1.72%
1Q
21.37%
Jan 2017
393.98%
Name

Thermo Fisher Scientific Inc

Chart & performance

D1W1MN
XNYS:TMO chart
P/E
38.25
P/S
5.78
EPS
18.22
Vol. 1Y
29.25%
Shs. 5Y
-1.13%
Rev. 5Y
6.70%
Div Yld LY
0.25%
Div Yld TTM
0.26%
Revenues
44.56b
+3.91%
3,791,617,0009,746,400,00010,498,000,00010,109,700,00010,788,700,00011,725,900,00012,509,900,00013,090,300,00016,889,600,00016,965,400,00018,274,100,00020,918,000,00024,358,000,00025,542,000,00032,218,000,00039,211,000,00044,915,000,00042,857,000,00042,879,000,00044,557,000,000
Net income
6.74b
+6.35%
168,935,000761,100,000994,200,000850,300,0001,035,600,0001,329,900,0001,177,900,0001,273,300,0001,894,400,0001,975,400,0002,021,800,0002,225,000,0002,938,000,0003,696,000,0006,375,000,0007,725,000,0006,950,000,0005,995,000,0006,335,000,0006,737,000,000
CFO
7.82b
-9.80%
405,654,0001,483,500,0001,420,200,0001,659,200,0001,497,800,0001,691,000,0002,039,500,0002,010,700,0002,619,600,0002,816,900,0003,156,300,0004,005,000,0004,543,000,0004,973,000,0008,289,000,0009,543,000,0009,154,000,0008,406,000,0008,667,000,0007,818,000,000
Dividend
Sep 15, 20260.47 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Related entities

Subsidiaries (33)
BmT GmbH Laborprodukte
ERIE FINANCE LIMITED
FEI
FEI COMPANY
FEI DEUTSCHLAND GMBH
FEI ELECTRON OPTICS B.V.
FEI ELECTRON OPTICS INTERNATIONAL B.V.
FEI EUROPE B.V.
FEI UK LIMITED
Fisher Scientific Company
FISHER SCIENTIFIC LUXEMBOURG, SARL
FISHER SCIENTIFIC SAS
FISHER SCIENTIFIC THE HAGUE V B.V.
LIFE TECHNOLOGIES CORPORATION
LIFE TECHNOLOGIES LIMITED
Power Sweden Holdings II Aktiebolag
PPD ITALIA S.R.L.
PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMITED
THERMO FISHER SCIENTIFIC (ECUBLENS) SARL
THERMO FISHER SCIENTIFIC (FINANCE I) B.V.

Key people

Marc Casper
Chairman of the Board, Chief Executive Officer · since 2026
James Meyer
Chief Financial Officer, Senior Vice President · since 2026
Executive Vice President · since 2024
Gianluca Pettiti
Executive Vice President · since 2021
Michael Shafer
Executive Vice President · since 2024
Michael Boxer
Senior Vice President, General Counsel · since 2022
Lisa Britt
Chief Human Resources Officer, Senior Vice President · since 2023
Joseph Holmes
Chief Accounting Officer, Vice President · since 2021
Lead Independent Director · since 2022
Director · since 2020
Independent Director · since 2010
Independent Director · since 2022
Independent Director · since 2012
Independent Director · since 2023
R. Alexandra Keith
Independent Director · since 2020
Karen Lynch
Independent Director · since 2025
James Mullen
Independent Director · since 2018
Debora Spar
Independent Director · since 2019
Independent Director · since 2017
IPO date
Aug 27, 1980
Employees
130,000
Domiciled in
US
Incorporated in
US
Legal address
C/O CAPITOL SERVICES, INC.
108 LAKELAND AVE.
DOVER, DE 19901
US
Headquarters
168 Third Avenue
Waltham, MA 02451
US
Previous name
Thermo Electron Corporation
Previous name
Thermo Electron Engineering Corporation

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT